glp 1 for cardiovascular disease Could GLP-1 medications be helpful your heart? Our experts weigh in on the potential benefits and side effects of the popular weight loss medications Cardiovascular Disease: ACC Guidelines for

This study aimed to evaluate the effectiveness and safety of orforglipron, a nonpeptide, oral GLP-1 receptor agonist, for weight loss in adults with obesity

In cardiovascular disease, emerging cardiac MRI techniques, including T1 mapping and extracellular volume fraction, offer quantitative assessment of myocardial fibrosis, while circulating collagen turnover markers may provide complementary information

The drug, manufactured by Novo Nordisk, is approved for the treatment of Type 2 diabetes but has been increasingly used for weight loss

There are times we may need to approve a drug before we cover it

In prodrug design strategies, lysine can be linked to active drug molecules through ester or amide bonds, allowing in vivo esterases or peptidases to release the parent drug in target tissues